Browse categories
CO ES GF IR LK LW PE RC WE
Press release: VUB-prof coordinates €15 million EU project on gene therapy for heart diseases

Press release: VUB-prof coordinates €15 million EU project on gene therapy for heart diseases

Gene therapies for patients with heart disease

Wednesday, March 20, 2019 — Professor Marinee Chuah of the VUB coordinates a research program on gene therapy for people with heart disease. The project involves fifteen million euros and thirteen international partners.

The European Union has allocated nearly €15 million to a research programme on new approaches to gene therapy for the treatment of heart diseases. To this end, the best methods for gene transfer to the heart will be sought. The project will include a clinical study of the most promising gene therapy approaches. The World Health Organisation estimates that 17.7 million people die each year from cardiovascular disease, an estimated 31% of all deaths worldwide. 

Professor Chuah: "This is a very exciting and important opportunity for this research consortium to find new ways to manage and treat heart disease. In Europe it is the biggest cause of death for people and any reduction in this mortality rate would be a very positive result for our European cooperation.

The research program, called CardioReGenix, is coordinated by Professor Marinee Chuah of the Vrije Universiteit Brussel (VUB). Thirteen institutions from six countries participate, including five companies. This five-year project was selected after a tough international competition.

The consortium includes a number of key players, including the Vrije Universiteit Brussel (Belgium), the University of East Finland (Finland), A2F-Associates Limited (UK), Medizinische Hochschule Hannover (Germany), King's College London (UK) University of Edinburgh (UK), Stichting VUMC (Netherlands), Batavia Bioscience BV (Netherlands), Finvector OY (Finland), Cardior Pharmaceuticals GmbH (Germany), Asphalion SL (Spain), Phosjois-Savon Sairaanhoitopiirin (Finland) and Christian-Albrechts-Universitaet zu Kiel (Germany).

 

More info

Professor Marinee Chuah

Free University of Brussels (VUB)

Deputy Head of the Department of Gene Therapy & Regenerative Medicine

Faculty of Medicine & Pharmacy

Brussels, Belgium

marinee.chuah@vub.be

Contact us
Sicco Wittermans Press Relations VUB
Sicco Wittermans Press Relations VUB
About Press - Vrije Universiteit Brussel

Vrije Universiteit Brussel is an internationally oriented university in Brussels, the heart of Europe. By providing excellent research and education on a human scale, VUB wants to make an active and committed contribution to a better society.

The World Needs You

The Vrije Universiteit Brussel assumes its scientific and social responsibility with love and decisiveness. That’s why VUB launched the platform De Wereld Heeft Je Nodig – The World Needs You, which brings together ideas, actions and projects based on six Ps. The first P stands for People, because that’s what it’s all about: giving people equal opportunities, prosperity, welfare, respect. Peace is about fighting injustice, big and small, in the world. Prosperity combats poverty and inequality. Planet stands for actions on biodiversity, climate, air quality, animal rights... With Partnership, VUB is looking for joint actions to make the world a better place. The sixth and last P is for Poincaré, the French philosopher Henri Poincaré, from whom VUB derives its motto that thinking should submit to nothing except the facts themselves. VUB is an ‘urban engaged university’, strongly anchored in Brussels and Europe and working according to the principles of free research.

www.vub.be/dewereldheeftjenodig

 


Press - Vrije Universiteit Brussel
Pleinlaan 2
1050 Brussel

Prezly - public relations software